About: The use of dexamethasone in the treatment of COVID-19

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: The use of dexamethasone in the treatment of COVID-19 Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : covidontheweb.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	The use of dexamethasone in the treatment of COVID-19
Creator	Lester, Mohammed Lester, Mr Pasyar, Ali Pasyar, Mr Sahin, Ali Sahin, Mr
Source	Elsevier; Medline; PMC
abstract	covid:ffe271d7afef2cfbf6fca7e1279c4eb3d2373ed4#abstract
has issue date	2020-07-09(xsd:dateTime)
bibo:doi	10.1016/j.amsu.2020.07.004
bibo:pmid	32754312
has license	no-cc
sha1sum (hex)	ffe271d7afef2cfbf6fca7e1279c4eb3d2373ed4
schema:url	https://doi.org/10.1016/j.amsu.2020.07.004
resource representing a document's title	The use of dexamethasone in the treatment of COVID-19
has PubMed Central identifier	PMC7343652
has PubMed identifier	32754312
schema:publication	Ann Med Surg (Lond)
resource representing a document's body	covid:ffe271d7afef2cfbf6fca7e1279c4eb3d2373ed4#body_text
is schema:about of	named entity 'dexamethasone' named entity 'COVID' named entity 'prognosis' named entity 'COVID-19' named entity 'immune cells' named entity 'pharmaceutical industry' named entity 'COVID-19' named entity 'dexamethasone' named entity '95% confidence interval' named entity 'pneumonia' named entity 'NHS England' named entity 'COVID-19' named entity 'naturally occurring' named entity 'adverse events' named entity 'COVid' named entity 'pharmacological' named entity 'chief medical officer' named entity 'inflammation' named entity 'COVID' named entity 'respiratory support' named entity 'respiratory support' named entity 'dexamethasone' named entity 'glucocorticoids' named entity 'COVID-19' named entity 'potential treatments' named entity 'inflammation' named entity 'NHS' named entity '0.80' named entity 'infection' named entity 'cortisol' named entity 'respiratory support' named entity 'dexamethasone' named entity 'dexamethasone' named entity 'ARDS' named entity 'lungs' named entity 'COVID' named entity 'COVID' named entity 'peer review' named entity 'open label study' named entity 'dexamethasone' named entity 'cortisol' named entity 'observer bias' named entity 'adverse events' named entity 'COVID' named entity 'COVID' named entity 'all-cause mortality' named entity 'respiratory support' named entity 'COVID-19' named entity 'respiratory complications' named entity 'anti-viral therapy' named entity 'hormone' named entity 'randomisation' named entity 'ARDS' named entity 'secretion' named entity 'COVid' named entity 'dexamethasone' named entity 'COVID-19 outbreak' named entity 'data monitoring committee' named entity 'Acute respiratory distress syndrome' named entity 'COVID' named entity 'oxygen therapy' named entity 'immune cells' named entity 'neutrophils' named entity 'Dexamethasone' named entity 'clinical trials' named entity 'COVID-19' named entity 'respiratory support' named entity 'dexamethasone' named entity 'dexamethasone' named entity '28 days' named entity 'COVID' named entity 'anti-inflammatory' named entity 'study protocol' named entity 'TNF-α' named entity 'COVID' named entity 'pneumonia'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software